The Role of p-VEGFR2/p-AKT and HDAC1 in Apatinib-associated Inhibition of Gallbladder Cancer Cell Growth
Exploratory Research and Hypothesis in Medicine · 30.07.2026 · 11 (3)
DOI: 10.14218/erhm.2025.00077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Exploratory Research and Hypothesis in Medicine, online erschienen am 29.06.2026. Verfasst von Wei Huang und 7 weiteren Autor:innen. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Apatinib has been shown to be efficacious in the treatment of gallbladder cancer. However, the underlying mechanisms remain unclear. This study aimed to explore pathways related to the antitumor effects of apatinib at the cellular level in gallbladder cancer.
Zitieren
APA
Huang, W., Pang, Y., Zhao, W., Xia, L., Wang, L., Nong, Y., Xiao, K., & Ning, Y. (2026). The Role of p-VEGFR2/p-AKT and HDAC1 in Apatinib-associated Inhibition of Gallbladder Cancer Cell Growth. Exploratory Research and Hypothesis in Medicine, 11(3). https://doi.org/10.14218/erhm.2025.00077
Vancouver
Huang W, Pang Y, Zhao W, Xia L, Wang L, Nong Y, et al. The Role of p-VEGFR2/p-AKT and HDAC1 in Apatinib-associated Inhibition of Gallbladder Cancer Cell Growth. Exploratory Research and Hypothesis in Medicine. 2026;11(3). doi:10.14218/erhm.2025.00077
BibTeX
@article{Huang2026,
author = {Huang, Wei and Pang, Yanmin and Zhao, Wenmei and Xia, Liang’e and Wang, Luting and Nong, Yingde and Xiao, Kai and Ning, Yichong},
title = {The Role of p-VEGFR2/p-AKT and HDAC1 in Apatinib-associated Inhibition of Gallbladder Cancer Cell Growth},
journal = {Exploratory Research and Hypothesis in Medicine},
year = {2026},
volume = {11},
number = {3},
doi = {10.14218/erhm.2025.00077}
}
EUVIMED